Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Patients Attending Regular Appointments in Their Clinics
and you are
between 48 and 100
years old
The phase for this study is not defined.
Show me locations

The purpose

HIV-infected patients with intermediate-high risk have a high prevalence of CAD and a substantial proportion of obstructive CAD. Degree of stenosis is associated with immunoactivation (lymphocyte and monocyte) and microbial translocation

Provided treatments

  • Biological: blood test
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02898896. The sponsor of the trial is University Hospital, Montpellier and it is looking for 200 volunteers for the current phase.
Official trial title:
Asymptomatic Obstructive Coronary Artery Disease (CAD) in Suppressed HIV-infected Patients ≥ 45 Years and 2 or More CV Risk Factors. Associations With Persistent Immune Activation and Microbial Translocation